These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25768432)

  • 1. The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica.
    Edwards J; Brown M; Peak E; Bartholomew B; Nash RJ; Hoffmann KF
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003604. PubMed ID: 25768432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
    Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and anthelmintic activity of 7-keto-sempervirol analogues.
    Crusco A; Bordoni C; Chakroborty A; Whatley KCL; Whiteland H; Westwell AD; Hoffmann KF
    Eur J Med Chem; 2018 May; 152():87-100. PubMed ID: 29698860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounds Derived from the Bhutanese Daisy, Ajania nubigena, Demonstrate Dual Anthelmintic Activity against Schistosoma mansoni and Trichuris muris.
    Wangchuk P; Pearson MS; Giacomin PR; Becker L; Sotillo J; Pickering D; Smout MJ; Loukas A
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004908. PubMed ID: 27490394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.
    Chakroborty A; Pritchard D; Bouillon ME; Cervi A; Cookson A; Wild C; Fenn C; Payne J; Holdsworth P; Capner C; O'Neill J; Padalino G; Forde-Thomas J; Gupta S; Smith BG; Fisher M; Lahmann M; Baird MS; Hoffmann KF
    Vet Parasitol; 2022 Sep; 309():109766. PubMed ID: 35926239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro.
    Becker B; Mehlhorn H; Andrews P; Thomas H; Eckert J
    Z Parasitenkd; 1980; 63(2):113-28. PubMed ID: 7456640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
    Whatley KCL; Padalino G; Whiteland H; Geyer KK; Hulme BJ; Chalmers IW; Forde-Thomas J; Ferla S; Brancale A; Hoffmann KF
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007693. PubMed ID: 31730617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthelmintic activity of triclabendazole.
    Coles GC
    J Helminthol; 1986 Sep; 60(3):210-2. PubMed ID: 3745874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
    Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal.
    Keiser J; Panic G; Vargas M; Wang C; Dong Y; Gautam N; Vennerstrom JL
    J Antimicrob Chemother; 2015; 70(6):1788-97. PubMed ID: 25691324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini.
    Keiser J; Shu-Hua X; Chollet J; Tanner M; Utzinger J
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1096-8. PubMed ID: 17194822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antihelmintic effect of fifteen tropical plant extracts on excysted flukes of Fasciola hepatica.
    Alvarez-Mercado JM; Ibarra-Velarde F; Alonso-Díaz MÁ; Vera-Montenegro Y; Avila-Acevedo JG; García-Bores AM
    BMC Vet Res; 2015 Feb; 11():45. PubMed ID: 25890066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening the Pathogen Box for Identification of New Chemical Agents with Anti-
    Machicado C; Soto MP; Timoteo O; Vaisberg A; Pajuelo M; Ortiz P; Marcos LA
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anthelmintic activity of (-)-6,6'-dinitrohinokinin against schistosomula and juvenile and adult worms of Schistosoma mansoni.
    Pereira AC; Silva ML; Souza JM; Laurentiz RS; Rodrigues V; Januário AH; Pauletti PM; Tavares DC; Filho AA; Cunha WR; Bastos JK; Magalhães LG
    Acta Trop; 2015 Sep; 149():195-201. PubMed ID: 26071648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
    de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
    Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of closantel on intrategumental pH in Schistosoma mansoni and Fasciola hepatica.
    Pax RA; Bennett JL
    J Parasitol; 1989 Feb; 75(1):169-71. PubMed ID: 2918439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; McCoy M; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2008 May; 153(1-2):52-64. PubMed ID: 18359570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.